Therapeutic potential of peptide deformylase inhibitors

被引:32
作者
Chen, D [1 ]
Yuan, Z [1 ]
机构
[1] Vicuron Pharmaceut, Fremont, CA 94555 USA
关键词
anticancer; antimalarial; deformylase inhibitor; metallohydrolase; new antibacterial drug; resistance; respiratory tract infection;
D O I
10.1517/13543784.14.9.1107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptide deformylase (PDF) is an attractive target for antibacterial drug discovery. Progress in the biological characterisation of the enzyme, coupled with newly obtained mechanistic and structural insight, enabled the pharmaceutical industry to discover potent PDF inhibitors that can be considered as clinical development candidates for this new class of antibacterial agents. The in vitro and in vivo data for several lead PDF inhibitors suggest that the current PDF inhibitors are most suitable for the treatment of respiratory tract infections and they are not cross-resistant to the current clinically used antibiotics. Two PDF inhibitors, BB-83698 and VIC-104959, have progressed to Phase I clinical trials by intravenous and oral administration, respectively. Both of these compounds show promising in vitro and in vivo efficacy and an excellent safety profile. The pharmacokinetics in humans for both of the compounds suggest the possibility of a twice-daily dosing regimen for clinical use. Thus far, all of the data suggest a promising future for this new class of antibacterial agents.
引用
收藏
页码:1107 / 1116
页数:10
相关论文
共 65 条
[51]  
NOEL AR, 2002, 42 ANN ICAAC M SAN D
[52]  
OSBORNE C, 1963, 44 ANN ICAAC M WASH
[53]   Control of peptide deformylase activity by metal cations [J].
Ragusa, S ;
Blanquet, S ;
Meinnel, T .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (03) :515-523
[54]   Peptide deformylase: A new type of mononuclear iron protein [J].
Rajagopalan, PTR ;
Yu, XC ;
Pei, DH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (50) :12418-12419
[55]   Oxygen-mediated inactivation of peptide deformylase [J].
Rajagopalan, PTR ;
Pei, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22305-22310
[56]   Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor [J].
Ramanathan-Girish, S ;
McColm, J ;
Clements, JM ;
Taupin, P ;
Barrowcliffe, S ;
Hevizi, J ;
Safrin, S ;
Moore, C ;
Patou, G ;
Moser, H ;
Gadd, A ;
Hoch, U ;
Jiang, V ;
Lofland, D ;
Johnson, KW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4835-4842
[57]   In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae [J].
Roblin, PM ;
Hammerschlag, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1447-1448
[58]  
RYDER NS, 2004, 44 ANN ICAAC M WASHT
[59]   An unusual peptide deformylase features in the human mitochondrial N-terminal methionine excision pathway [J].
Serero, A ;
Giglione, C ;
Sardini, A ;
Martinez-Sanz, J ;
Meinnel, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52953-52963
[60]  
SUN H, 2004, 33 ANN M AM COLL CLI